Apple to Testify It Sees No Need to Deploy Google Alternative
Apple Inc.’s services chief, set to testify in Washington Tuesday, plans to defend the lucrative deal that made
2023-09-26 17:45
Sweden’s Producer Prices Slump Most on Record on Energy
Swedish factory-gate prices plunged the most on record in August from a year earlier, led by energy, suggesting
2023-09-26 17:26
Japan Warns Again on Yen After Dollar Breaches 149 Mark
Japan’s finance minister issued his second salvo of warnings to players in foreign-exchange markets in a day after
2023-09-26 17:24
China powers global aluminium output to record high: Andy Home
By Andy Home LONDON (Reuters) -Global production of primary aluminium hit an all-time high in August, with the world's smelters
2023-09-26 17:23
Worldly Appoints Francois Thrower as New CFO
SAN FRANCISCO--(BUSINESS WIRE)--Sep 26, 2023--
2023-09-26 17:19
US yields hit 2007 levels as Fed signals, shutdown fears stoke angst
By Kevin Buckland and Lawrence White TOKYO/LONDON U.S. Treasury yields hit a peak not seen since the early
2023-09-26 17:18
Mercedes S-Class, Porsche Stand to Lose Most in China EV Row
The European Union’s probe into Beijing’s electric-vehicle subsidies is meant to protect its carmakers from a flood of
2023-09-26 17:17
Thailand approves $908 million plan to suspend farmers' debts for 3 years
BANGKOK (Reuters) -Thailand's cabinet has approved a plan to suspend debt repayments for millions of farmers for three years at
2023-09-26 16:55
NIPPON KINZOKU’s Precise Steel Profiles Realize "Hybrid Processing" which Brings Low Cost and Environmental Performance
TOKYO--(BUSINESS WIRE)--Sep 26, 2023--
2023-09-26 16:29
South Korea to Shore Up Housing Supply With More Loan Guarantees
South Korea plans to increase guarantees for short-term property loans as part of its efforts to address potential
2023-09-26 16:29
Zayo Supercharges Connectivity With Fully-Enabled 400G European Network
BOULDER, Colo.--(BUSINESS WIRE)--Sep 26, 2023--
2023-09-26 16:27
After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies
2023-09-26 16:26